newsfilter
← Latest News
Business Wire·

Alnylam Pharmaceuticals Announces Changes to Board of Directors

– Mike Bonney and Carolyn Bertozzi to Depart; Company Appoints Stuart Arbuckle as New Independent Director – Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), the leading RNAi therapeutics company, today announced changes